Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: Lipid nanoparticles versus polymeric nanoparticles

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 371-385

  Hwang, Tsong Long ^a,b   Aljuffali, Ibrahim A ^c   Lin, Chwan Fwu ^d   Chang, Yuan Ting ^b   Fang, Jia You ^b,d,e  

^a Graduate Institute of Natural Products   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cationic surfactant; Inflammation; Nanoparticle; Neutrophil

Indexed keywords

CATIONIC SURFACTANT; CETRIMIDE; LACTATE DEHYDROGENASE; LIPID NANOPARTICLE; NANOPARTICLE; POLYMERIC NANOPARTICLE; SOYAETHYL MORPHOLINIUM ETHOSULFATE; UNCLASSIFIED DRUG; CATION; LIPID; POLYMER;

ADULT; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISPERSION; ELECTRON MICROSCOPY; ENZYME RELEASE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LASER MICROSCOPY; LEUKOCYTE FUNCTION; MORPHOLOGY; NANOMEDICINE; NEUTROPHIL; NORMAL HUMAN; PARTICLE SIZE; SEDIMENTATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; ZETA POTENTIAL; CELL CULTURE; CHEMISTRY; DRUG EFFECTS;

CATIONS; CELL SURVIVAL; CELLS, CULTURED; CETRIMONIUM COMPOUNDS; HUMANS; LIPIDS; NANOPARTICLES; NEUTROPHILS; PARTICLE SIZE; POLYMERS;

EID: 84920929340     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S73017     Document Type: Article

References (45)

1. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010; 363(25):2434-2443.
2. Fang CL, Al-Suwayeh SA, Fang JY. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol. 2013;7(1): 41-55.
3. Tsai MJ, Wu PC, Huang YB, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm. 2012;423(2):461-470.
4. Sah H, Thoma LA, Desu HR, Sah E, Wood GC. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomedicine. 2013;8:747-765.
5. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505-522.
6. Ramadan A, Lagarce F, Tessier-Marteau A, et al. Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. Int J Nanomedicine. 2011;6:2941-2951.
7. Pan TL, Wang PW, Al-Suwayeh SA, Huang YJ, Fang JY. Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk. Food Chem Toxicol. 2012;50(11):3892-3901.
8. Lonez C, Vandenbranden M, Ruysschaert JM. Cationic liposomal lipids: from gene carriers to cell signaling. Prog Lipid Res. 2008;47(5): 340-347.
9. Arisaka M, Nakamura T, Yamada A, Negishi Y, Aramaki Y. Involvement of protein kinase Cdelta in induction of apoptosis by cationic liposomes in macrophage-like RAW264.7 cells. FEBS Lett. 2010;584(5): 1016-1020.
10. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Ann Rev Immunol. 2012;30: 459-489.
11. Abrikossova N, Skoglund C, Ahrén M, Bengtsson T, Uvdal K. Effects of gadolinium oxide nanoparticles on the oxidative burst from human neutrophil granulocytes. Nanotechnology. 2012; 23(27):275101.
12. Babin K, Antoine F, Goncalves DM, Girard D. TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils. Toxicol Lett. 2013;221(1):57-63.
13. Aiello C, Andreozzi P, La Mesa C, Risuleo G. Biological activity of SDS-CTAB cat-anionic vesicles in cultured cells and assessment of their cytotoxicity ending in apoptosis. Colloids Surf B Biointerfaces. 2010; 78(2):149-154.
14. Hwang TL, Yeh SH, Leu YL, Chern CY, Hsu HC. Inhibition of superoxide anion and elastase release in human neutrophils by 3′-isoproxychalcone via a cAMP-dependent pathway. Br J Pharmacol. 2006;148(1): 78-87.
15. Hwang TL, Wang CC, Kuo YH, et al. The hederagenin saponin SMG-1 is a natural FMLP receptor inhibitor that suppresses human neutrophil activation. Biochem Pharmacol. 2010;80(8):1190-1200.
16. Lin CH, Fang YP, Al-Suwayeh SA, Yang SY, Fang JY. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull. 2013;36(2):276-286.
17. Iwaoka S, Nakamura T, Takano S, Tsuchiya S, Aramaki Y. Cationic liposomes induce apoptosis through p38 MAP kinase-caspase-8-Bid pathway in macrophage-like RAW264.7 cells. J Leukoc Biol. 2006; 79(1):184-191.
18. de Lima R, do Espirito, Santo Pereira A, Porto RM, Fraceto LF. Evaluation of cytoand genotoxicity of poly(lactide-co-glycolide) nanoparticles. Journal of Polymers and the Environment. 2011;19(1): 196-202.
19. Xiong S, George S, Yu H, et al. Size influences the cytotoxicity of poly(lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO(2)) nanoparticles. Arch Toxicol. 2013;87(6):1075-1086.
20. Silliman CC, Elzi DJ, Ambruso DR, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol. 2003;73(4): 511-524.
21. Cury-Boaventura MF, Gorjão R, de Lima TM, et al. Toxicity of a soybean oil emulsion on human lymphocytes and neutrophils. JPEN J Parenter Enteral Nutr. 2006;30(2):115-123.
22. Loh JW, Yeoh G, Saunders M, Lim LY. Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol Appl Pharmacol. 2010;249(2):148-157.
23. Caielli S, Banchereau J, Pascual V. Neutrophils come of age in chronic inflammation. Curr Opin Immunol. 2012;24(6):671-677.
24. Wright HL, Moots RJ, Bucknall RC, Edwards SW. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford). 2010; 49(9):1618-1631.
25. Huang CC, Aronstam RS, Chen DR, Huang YW. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol In Vitro. 2010;24(1): 45-55.
26. Bhattacharjee S, de Haan LHJ, Evers NM, et al. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol. 2010;7:25.
27. Flannagan RS, Cosío G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 2009;7(5): 355-366.
28. Burgos RA, Conejeros I, Hidalgo MA, Werling D, Hermosilla C. Calcium influx, a new potential therapeutic target in the control of neutrophil-dependent inflammatory diseases in bovines. Vet Immunol Immunopathol. 2011;143(1-2):1-10.
29. Salmon MD, Ahluwalia J. Pharmacology of receptor operated calcium entry in human neutrophils. Int Immunopharmacol. 2011;11(2): 145-148.
30. Arisaka M, Takano K, Negishi Y, Arima H, Aramaki Y. Involvement of lipid rafts in macrophage apoptosis induced by cationic liposomes. Arch Biochem Biophys. 2011;508(1):72-77.
31. Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG. Lipidbased nanotherapeutics for siRNA delivery. J Intern Med. 2010;267(1): 9-21.
32. Grabowskin N, Hillaireau H, Vergnaud J, et al. Toxicity of surfacemodified PLGA nanoparticles toward lung alveolar epithelial cells. Int J Pharm. 2013;454(2):686-694.
33. Kumazawa R, Watari F, Takashi N, Tanimura Y, Uo M, Totsuka Y. Effects of Ti ions and particles on neutrophil function and morphology. Biomaterials. 2002;23(17):3757-3764.
34. Bréchard S, Tschirhart EJ. Regulation of superoxide production in neutrophils: role of calcium influx. J Leukoc Biol. 2008;84(5): 1223-1237.
35. George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through ion doping. ACS Nano. 2009;4(1):15-29.
36. El Zein N, Badran B, Sariban E. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1. Cell Calcium. 2008; 43(3):270-284.
37. Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23: 197-223.
38. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med. 2007;42(2):153-164.
39. Baron S, Struyf S, Wuytack F, et al. Contribution of intracellular Ca2+ stores to Ca2+ signaling during chemokinesis of human neutrophil granulocytes. Biochim Biophys Acta. 2009;1793(6):1041-1049.
40. Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev. 2007;59(8):718-728.
41. Mainardes RM, Gremião MPD, Brunetti IL, Da Fonseca LM, Khalil NM. Zidovudine-loaded PLA and PLA-PEG nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells. J Pharm Sci. 2009;98(1):257-267.
42. Liu CW, Lin WJ. Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin. Int J Nanomedicine. 2012;7:4749-4767.
43. Goncalves DM, de Liz R, Girard D. Activation of neutrophils by nanoparticles. ScientificWorldJournal. 2011;11:1877-1885.
44. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6(1):12-21.
45. Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir. 2009;25(4):2369-2377.